Candesartan Cilexetil was first introduced by Ani Pharmaceuticals Inc in its drug Atacand on Jun 4, 1998. 7 different companies have introduced drugs containing Candesartan Cilexetil.

Candesartan Cilexetil Patents

Given below is the list of patents protecting Candesartan Cilexetil, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Atacand	US5534534 (Pediatric)	Pharmaceutical compositions for oral use and method of preparing them	Jan 09, 2014 (Expired)	Ani Pharms
Atacand	US5534534	Pharmaceutical compositions for oral use and method of preparing them	Jul 09, 2013 (Expired)	Ani Pharms
Atacand	US5196444 (Pediatric)	1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof	Dec 04, 2012 (Expired)	Ani Pharms

Add above patents to watchlist

Candesartan Cilexetil's Family Patents

Full family tree

Candesartan Cilexetil Generic API Manufacturers

Several generic applications have been filed for Candesartan Cilexetil. The first generic version for Candesartan Cilexetil was by Mylan Pharmaceuticals Inc and was approved on May 3, 2013. And the latest generic version is by Prinston Pharmaceutical Inc and was approved on Aug 21, 2023.

Given below is the list of companies who have filed for Candesartan Cilexetil generic, along with the locations of their manufacturing plants worldwide.